BIOGEN INC's ticker is and the CUSIP is 09062X903. A total of 10 filers reported holding BIOGEN INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,350,542 | +37.0% | 114,200 | +51.9% | 0.01% | +28.6% |
| Q2 2023 | $21,420,720 | -29.5% | 75,200 | -31.2% | 0.01% | -41.7% |
| Q1 2023 | $30,388,679 | -51.6% | 109,300 | -51.7% | 0.01% | -58.6% |
| Q4 2022 | $62,722,380 | -47.1% | 226,500 | -49.0% | 0.03% | -44.2% |
| Q3 2022 | $118,521,000 | +85.4% | 443,900 | +41.6% | 0.05% | +92.6% |
| Q2 2022 | $63,915,000 | – | 313,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CLEAR STREET MARKETS LLC | 40 | $1,161,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 30 | $871,000 | 0.14% |
| SIMPLEX TRADING, LLC | 638 | $18,516,000 | 0.07% |
| GROUP ONE TRADING, L.P. | 17,900 | $5,195,000 | 0.04% |
| SG Americas Securities, LLC | 40,700 | $658,000 | 0.01% |
| Allianz Asset Management GmbH | 22,300 | $6,472,000 | 0.01% |
| JPMORGAN CHASE & CO | 100,500 | $29,169,000 | 0.01% |